These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34393252)

  • 21. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
    Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
    Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
    Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAFRO syndrome: A case report and review of the literature.
    Hou T; Dhillon J; Xiao W; Jaffe ES; Sands AM; Neppalli V; Deeb G; Zhang N
    Hum Pathol (N Y); 2017 Nov; 10():1-4. PubMed ID: 31608209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
    Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
    Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?
    Takai K
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with
    Hibi A; Mizuguchi K; Yoneyama A; Kasugai T; Kamiya K; Kamiya K; Ito C; Kominato S; Miura T; Koyama K
    Ren Replace Ther; 2018; 4(1):16. PubMed ID: 34171004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
    Wu CB; Zhang HY; Shao SH; Dou LW; Zhou QY; Liu Y; Gao WB; Zhu JH
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):624-628. PubMed ID: 32164119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].
    Sumi C; Toki Y; Funayama T; Saito T; Hatayama M; Yamamoto M; Shindo M; Yuzawa S; Tanino M; Okumura T
    Rinsho Ketsueki; 2023; 64(4):265-270. PubMed ID: 37121770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
    Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
    Miura K; Nishimaki-Watanabe H; Takahashi H; Nakagawa M; Otake S; Hamada T; Koike T; Iizuka K; Takeuchi Y; Kurihara K; Endo T; Ito S; Nukariya H; Namiki T; Hayashi Y; Nakamura H
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?
    Fujimoto S; Sakai T; Kawabata H; Kurose N; Yamada S; Takai K; Aoki S; Kuroda J; Ide M; Setoguchi K; Tsukamoto N; Iwao-Kawanami H; Kawanami T; Mizuta S; Fukushima T; Masaki Y
    Am J Hematol; 2019 Sep; 94(9):975-983. PubMed ID: 31222819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.
    Sato H; Kanno A; Sato M; Endo A; Ito H; Ohara T; Shirota Y; Sumitomo K; Mori T; Furukawa K
    Front Immunol; 2023; 14():1266187. PubMed ID: 37901232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.
    Srkalovic G; Marijanovic I; Srkalovic MB; Fajgenbaum DC
    Bosn J Basic Med Sci; 2017 May; 17(2):81-84. PubMed ID: 28135567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Thrombocytopenia, Anasarca (Edema, Pleural Effusion, and Ascites), Fever, Reticulin Fibrosis/Renal Dysfunction, and Organomegaly (TAFRO) Syndrome Initially Not Presenting With Thrombocytopenia: A Role of Immature Platelet Fraction.
    Kanda M; Kitamura K; Saito A; Hayashi K; Suzuki T
    Cureus; 2024 Apr; 16(4):e58772. PubMed ID: 38779246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe systemic inflammation mimicking TAFRO syndrome following COVID-19.
    Tane M; Kosako H; Hosoi H; Tabata K; Hiroi T; Osawa K; Iwamoto R; Murata S; Mushino T; Murata SI; Araki SI; Fujii T; Sonoki T
    Int J Hematol; 2023 Sep; 118(3):374-380. PubMed ID: 37000328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
    Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
    CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.